VASPIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Zendy

Maryana Gorshunska | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

VASPIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Author(s) -

Maryana Gorshunska

Publication year - 2021

Publication title -

problems of endocrine pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.141

H-Index - 2

eISSN - 2518-1432

pISSN - 2227-4782

DOI - 10.21856/j-pep.2015.3.03

Subject(s) - medicine , adiponectin , adipokine , resistin , type 2 diabetes , endocrinology , diabetes mellitus , type 2 diabetes mellitus , glycemic , leptin , obesity , insulin resistance

It was examined 61 patients with type 2 diabetes (m/f: 34/27, disease duration 6.29 ± 0.67 years), overweight or obese, with suboptimal or poor glycemic control, coronary heart disease and/or hypertension were observed. There were no significant changes in the circulating vaspin concentration with respect to control individuals as well as in groups with different gender or the presence/absence of symptomatic coronary heart disease. The patients had no functional relation between the vaspin and parameters of carbohydrate/lipid dismetabolism. The detected relation of vaspin normal levels to proinflammatory resistin (positive) and anti-atherogenic total and highmolecular adiponectin (negative), as well as direct association with the pro-atherogenic adipocytokines leptin and osteoprotegerin only in the preclinical stage of cardiovascular disease development may indicate a compensatory nature of this adipokine influence on vascular complications in type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research